This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

AGA Research Foundation Receives $200K Gift From Shire Pharmaceuticals

BETHESDA, Md., April 23, 2013 /PRNewswire-USNewswire/ -- The American Gastroenterological Association (AGA) Research Foundation is pleased to welcome Shire Pharmaceuticals as a supporter of the foundation's endowment.

The AGA Research Foundation provides research grants to young investigators in gastroenterology and hepatology.  The foundation's grants transform young researchers' lives by encouraging them to embark on and continue careers in research. Many ultimately make discoveries that improve patient care.

"Young scientists funded by the AGA Research Foundation are working to improve our understanding of the pathogenesis of gastrointestinal and liver diseases. AGA applauds Shire's support of these young researchers, who hold the keys to the patient care improvements of the future," said Nicholas F. LaRusso, MD, AGAF, chair of the AGA Research Foundation.

Shire Pharmaceuticals' $200,000 gift to the AGA Research Foundation endowment will help ensure that researchers have the tools they need to discover ways to better diagnose, treat and cure digestive diseases. Dedicated to enabling people with life-altering conditions to lead better lives, Shire develops and provides healthcare in the areas of behavioral health and gastro-intestinal (GI) conditions, rare diseases, and regenerative medicine, as well as other symptomatic conditions treated by specialist physicians.

"Shire's support of the AGA Research Foundation reflects our long-standing commitment to fostering innovation to benefit GI patients," said Shire Senior Vice President Roger Adsett, who leads the company's GI business.  "As a leader in GI health, we are dedicated to finding the future of GI and are proud to assist those who are seeking next-generation solutions."

Many breakthroughs have been achieved through gastroenterological and hepatological research over the past century, forming the basis of the modern medical practice. The AGA Research Foundation is working to continue this tradition of discovery and ultimately improve the lives of patients with digestive diseases.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,131.97 +100.83 0.59%
S&P 500 1,998.98 +14.85 0.75%
NASDAQ 4,552.7590 +33.8570 0.75%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs